Search Results - "Pereira, Brian J.G"

KDOQI US Commentary on the KDIGO Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in CKD by Gordon, Craig E., MD, MS, Balk, Ethan M., MD, MPH, Becker, Bryan N., MD, Crooks, Peter A., MD, Jaber, Bertrand L., MD, MS, Johnson, Cynda A., MD, MBA, Michael, Maureen A., BSN, MBA, Pereira, Brian J.G., MD, Uhlig, Katrin, MD, MS, Levin, Adeera, MD

“…KDIGO (Kidney Disease: Improving Global Outcomes) is an international initiative with a key mission of developing clinical practice guidelines in the area of…”
Get full text

Ferumoxytol as an Intravenous Iron Replacement Therapy in Hemodialysis Patients by Provenzano, Robert, Schiller, Brigitte, Rao, Madhumathi, Coyne, Daniel, Brenner, Louis, Pereira, Brian J G

“…Intravenous iron is a key component of anemia management for chronic kidney disease (CKD). Ferumoxytol is a unique intravenous iron product that can be…”
Get full text

Mitochondrial DNA Injury and Mortality in Hemodialysis Patients by RAO, Madhumathi, LIJUN LI, DEMELLO, Caren, DAQING GUO, JABER, Bertrand L, PEREIRA, Brian J. G, BALAKRISHNAN, Vaidyanathapuram S

“…The role of mitochondrial injury in the pathogenesis of complications of uremia is incompletely defined, although diminished bioenergetic capacity and the…”
Get full text

Mortality after kidney transplant failure: The impact of non-immunologic factors by Gill, John S., Abichandani, Rekha, Kausz, Annamaria T., Pereira, Brian J.G.

“…Mortality after kidney transplant failure: The impact of non-immunologic factors. One third of cadaveric kidney transplant recipients suffer graft loss within…”
Get full text

Plasma interleukin-6 predicts cardiovascular mortality in hemodialysis patients by Rao, Madhumathi, Guo, Daqing, Perianayagam, Mary C., Tighiouart, Hocine, Jaber, Bertrand L., Pereira, Brian J.G., Balakrishnan, Vaidyanathapuram S.

“…Background: Interleukin-6 (IL-6) is a mediator and marker of the chronic inflammatory process that is responsible for much of the morbidity and mortality seen…”
Get full text

Anemia: An early complication of chronic renal insufficiency by Kazmi, Waqar H., Kausz, Annamaria T., Khan, Samina, Abichandani, Rekha, Ruthazer, Robin, Obrador, Gregorio T., Pereira, Brian J.G.

“…The strong association between anemia and cardiovascular complications among patients with end-stage renal disease suggests that anemia during chronic renal…”
Get full text

Does predialysis nephrology care influence patient survival after initiation of dialysis? by Khan, Samina S., Xue, Jay L., Kazmi, Waqar H., Gilbertson, David T., Obrador, Gregorio T., Pereira, Brian J.G., Collins, Allan J.

“…Does predialysis nephrology care influence patient survival after initiation of dialysis? Early nephrology referral of patients with chronic kidney disease…”
Get full text

Effect of hepatitis C infection and renal transplantation on survival in end-stage renal disease by PEREIRA, B. J. G, NATOV, S. N, BOUTHOT, B. A, MURTHY, B. V. R, RUTHAZER, R, SCHMID, C. H, LEVEY, A. S

Get full text

Chronic kidney disease: The distribution of health care dollars by Peter, Wendy L.St, Khan, Samina S., Ebben, James P., Pereira, Brian J.G., Collins, Allan J.

“…Chronic kidney disease: The distribution of health care dollars. The cost of care for end-stage renal disease (ESRD) is known to be high. The factors…”
Get full text

Relationship among catheter insertions, vascular access infections, and anemia management in hemodialysis patients by Roberts, Tricia L., Obrador, Gregorio T., St. Peter, Wendy L., Pereira, Brian J.G., Collins, Allan J.

“…Relationship among catheter insertions, vascular access infections, and anemia management in hemodialysis patients. Arteriovenous fistulas are the recommended…”
Get full text

Intractable anemia among hemodialysis patients: A sign of suboptimal management or a marker of disease? by Kausz, Annamaria T., Solid, Craig, Pereira, Brian J.G., Collins, Allan J., St. Peter, Wendy

“…Background: Most incident hemodialysis (HD) patients who initiate dialysis therapy with anemia usually can achieve a hemoglobin (Hb) level of 11 g/dL or…”
Get full text

Trends in anemia at initiation of dialysis in the United States by Obrador, Gregorio T., Roberts, Tricia, St. Peter, Wendy L., Frazier, Eric, Pereira, Brian J.G., Collins, Allan J.

“…Trends in anemia at initiation of dialysis in the United States. Anemia almost invariably develops in patients with chronic renal insufficiency (CRI) and is…”
Get full text

Role of prohepcidin, inflammatory markers and iron status in resistance to rhEPO therapy in hemodialysis patients by Costa, Elísio, Pereira, Brian J G, Rocha-Pereira, Petronila, Rocha, Susana, Reis, Flávio, Castro, Elisabeth, Teixeira, Frederico, Miranda, Vasco, do Sameiro Faria, Maria, Loureiro, Alfredo, Quintanilha, Alexandre, Belo, Luís, Santos-Silva, Alice

“…The aim of our study was to assess possible relations between prohepcidin, iron status and inflammatory markers in hemodialysis (HD) patients, as well as its…”
Get more information

Protective Effect of Intravenous Levocarnitine on Subsequent-Month Hospitalization Among Prevalent Hemodialysis Patients, 1998 to 2003 by Weinhandl, Eric D., MS, Rao, Madhumati, MD, Gilbertson, David T., PhD, Collins, Allan J., MD, Pereira, Brian J.G., MD

“…Background Levocarnitine deficiency in hemodialysis patients is common. Although the effect of intravenous levocarnitine therapy was studied in small trials,…”
Get full text

Chronic kidney disease in India--a hidden epidemic by Rao, Madhumati, Pereira, Brian J G

Get full text

Chronic kidney disease in the United States: an underrecognized problem by Obrador, Gregorio T, Pereira, Brian J G, Kausz, Annamaria T

“…The continued growth of the population with end-stage renal disease (ESRD) is partially related to the underrecognition of earlier stages of chronic kidney…”
Get more information

Optimal anemia management reduces cardiovascular morbidity, mortality, and costs in chronic kidney disease by Rao, Madhumathi, Pereira, Brian J.G.

Get full text

Transmission of Hepatitis C Virus by Organ Transplantation by Pereira, Brian J.G, Milford, Edgar L, Kirkman, Robert L, Levey, Andrew S

“…LIVER disease is an important cause of morbidity J and mortality in renal-transplant recipients, with abnormalities of liver function occurring in 7 to 24…”
Get full text

Dialyzer membrane type and reuse practice influence polymorphonuclear leukocyte function in hemodialysis patients by Rao, Madhumathi, Guo, Daqing, Jaber, Bertrand L., Sundaram, Sumuk, Cendoroglo, Miguel, King, Andrew J., Pereira, Brian J.G., Balakrishnan, Vaidyanathapuram S., The Hemo Study Group

“…Dialyzer membrane type and reuse practice influence polymorphonuclear leukocyte function in hemodialysis patients. Polymorphonuclear leukocyte (PMNL)…”
Get full text

A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy by Mathur, Mohit, Barratt, Jonathan, Chacko, Bobby, Chan, Tak Mao, Kooienga, Laura, Oh, Kook-Hwan, Sahay, Manisha, Suzuki, Yusuke, Wong, Muh Geot, Yarbrough, Jill, Xia, Jing, Pereira, Brian J.G.

“…In this trial involving patients with IgA nephropathy, sibeprenlimab, a humanized IgG2 monoclonal antibody that blocks a proliferation-inducing ligand,…”
Get full text